Fig. 3. CZL80 attenuates the long-term motor function recovery after photothrombotic stroke.

a Diagram showing the design of the experiments in this figure. CZL80 (10 or 30 mg·kg⁻¹·d⁻¹) or vehicle was intraperitoneally injected daily during Day 4-7 after photothrombosis (PT) and motor function was measured on Day8, 15, 29, 43 after PT. b Foot fault of left forelimb in the grid-walking task and (c) Forelimb symmetry in the cylinder task were determined. All results were represented as means ± SEM (n = 9 per group). Statistical significance was determined using one-way ANOVA with Tukey’s post hoc test, ^**P < 0.01 and ^***P < 0.001 vs. PT.